InnovationRx: Battle Of The AI Medical Scribes

Deepmind News

InnovationRx: Battle Of The AI Medical Scribes
Generative AiAlphafoldNovo Nordisk
  • 📰 ForbesTech
  • ⏱ Reading Time:
  • 77 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 51%
  • Publisher: 59%

Alex Knapp is a senior editor at Forbes covering healthcare, science, and cutting edge technology who joined Forbes in 2011. He's written dozens of profiles of entrepreneurs across a variety of fields and done deep dives into technological trends from superconductors to space travel to pharmaceuticals.

$13.5 million in revenue in the first quarter of 2024, up 40% from the previous year. But by Tuesday’s close, a day after the earnings report, the stock was down more than 50% to $1.15 per share. The reason?told analysts the company was lowering its 2024 revenue outlook to a range of $52 million to $55 million from previous estimates of $60 million to $62 million.

, which was released for general availability last month following a pilot with HCA Healthcare. It’s faster and cheaper than the human-in-the-loop version. Prior to the earnings call, Forbes caught up with Augmedix founder and chief strategy officer Ian Shakil, who provided insight into how the company plans to differentiate itself.

“The is hard as heck,” said Shakil, due to terrible acoustics, patient rooms separated by curtains, multiple voices and doctors constantly switching between bedsides. Augmedix offers athat includes a lapel mic, rather than having to put a phone down on a surface. The idea is to conquer complex specialties, like emergency and oncology, said Shakil. “If we can show strength and differentiation there, we can win accounts.

“The other benefit, which is really exciting, is team-based documentation,” he said. In a hospital, there can be multiple doctors, nurses and other clinicians treating a patient. “To the degree these hospitals are partnering, innovating and making their rooms smart,” said Shakil, “it enables us to kind of ride those rails.

Our community is about connecting people through open and thoughtful conversations. We want our readers to share their views and exchange ideas and facts in a safe space.Insults, profanity, incoherent, obscene or inflammatory language or threats of any kindContinuous attempts to re-post comments that have been previously moderated/rejectedAttempts or tactics that put the site security at riskProtect your community.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ForbesTech /  🏆 318. in US

Generative Ai Alphafold Novo Nordisk Oscar Health Gates Foundation

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

President Biden’s Latest Attack On The Economy: Smother The InternetPresident Biden’s Latest Attack On The Economy: Smother The InternetSteve Forbes is Chairman and Editor-in-Chief of Forbes Media.
Read more »

Biden Wants To Take Your CarBiden Wants To Take Your CarSteve Forbes is Chairman and Editor-in-Chief of Forbes Media.
Read more »

InnovationRx: Deepmind Unveils Its New Protein-Folding AI Model AlphaFold 3InnovationRx: Deepmind Unveils Its New Protein-Folding AI Model AlphaFold 3I'm a senior writer at Forbes covering healthcare technology, and I also write the InnovationRX newsletter. I was previously a healthcare reporter for POLITICO covering the European Union from Brussels and the New Jersey Statehouse from Trenton. I was a 2019-2020 Knight-Bagehot Fellow in business and economics reporting at Columbia University.
Read more »

InnovationRx: Legislation Could Prevent Pharma Companies From Working With Chinese ContractorsInnovationRx: Legislation Could Prevent Pharma Companies From Working With Chinese ContractorsI'm a senior editor at Forbes covering healthcare, science, and cutting edge technology. I also co-author the InnovationRX newsletter.
Read more »

InnovationRx: FDA Approves Abbott’s Dissolvable StentsInnovationRx: FDA Approves Abbott’s Dissolvable StentsI'm a senior editor at Forbes covering healthcare, science, and cutting edge technology. I also co-author the InnovationRX newsletter.
Read more »

InnovationRx: Chelsea Clinton Invests In 24/7 Pediatrics StartupInnovationRx: Chelsea Clinton Invests In 24/7 Pediatrics StartupI'm a senior writer at Forbes covering healthcare technology, and I also write the InnovationRX newsletter. I was previously a healthcare reporter for POLITICO covering the European Union from Brussels and the New Jersey Statehouse from Trenton. I was a 2019-2020 Knight-Bagehot Fellow in business and economics reporting at Columbia University.
Read more »



Render Time: 2025-03-10 18:39:32